These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patients with craniopharyngiomas: therapeutical difficulties with growth hormone. Cannavò S; Marini F; Trimarchi F J Endocrinol Invest; 2008 Sep; 31(9 Suppl):56-60. PubMed ID: 19020388 [TBL] [Abstract][Full Text] [Related]
4. GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Karavitaki N; Warner JT; Marland A; Shine B; Ryan F; Arnold J; Turner HE; Wass JA Clin Endocrinol (Oxf); 2006 May; 64(5):556-60. PubMed ID: 16649976 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction. Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277 [TBL] [Abstract][Full Text] [Related]
6. Growth hormone treatment in pituitary insufficiency: selected cases of children with craniopharyngioma and medulloblastoma. Kedzia A; Obara-Moszyńska M; Korman E; Rabska-Pietrzak B; Kopinski P; Trojan J; Goździcka-Józefiak A Rocz Akad Med Bialymst; 2003; 48():28-33. PubMed ID: 14737937 [TBL] [Abstract][Full Text] [Related]
7. The effect of growth hormone on pituitary tumour growth. Herring R; Russell-Jones D Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):365-8. PubMed ID: 20498595 [TBL] [Abstract][Full Text] [Related]
9. DIFFERENTIAL REGULATION OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVITY IN PATIENTS WITH DIFFERING ETIOLOGIES OF HYPOPITUITARISM. Agha A; Behan LA; Forde H; Taylor NF; Smith D; Thompson CJ; Drake WM; Monson JP Endocr Pract; 2018 Oct; 24(10):875-881. PubMed ID: 29975580 [TBL] [Abstract][Full Text] [Related]
10. [Anterior pituitary insufficiencies in children]. Warnet A Soins; 1989 Mar; (522):9-14. PubMed ID: 2727739 [No Abstract] [Full Text] [Related]
11. HORMONE SUBSTITUTION AFTER GASTRIC BYPASS SURGERY IN PATIENTS WITH HYPOPITUITARISM SECONDARY TO CRANIOPHARYNGIOMA. Wolf P; Winhofer Y; Smajis S; Kruschitz R; Schindler K; Gessl A; Riedl M; Vila G; Raber W; Langer F; Prager G; Ludvik B; Luger A; Krebs M Endocr Pract; 2016 May; 22(5):595-601. PubMed ID: 26789341 [TBL] [Abstract][Full Text] [Related]
12. Acute pancreatitis in a girl with panhypopituitarism due to craniopharyngioma on growth hormone treatment. A combination of risk factors. Faienza MF; Delvecchio M; Indrio F; Francavilla R; Acquafredda A; Cavallo L Horm Res; 2009; 71(6):372-5. PubMed ID: 19506396 [TBL] [Abstract][Full Text] [Related]
13. Growth in children with a craniopharyngioma. Blethen SL Pediatrician; 1987; 14(4):242-5. PubMed ID: 2840646 [TBL] [Abstract][Full Text] [Related]
14. Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database). Darendeliler F; Karagiannis G; Wilton P; Ranke MB; Albertsson-Wikland K; Anthony Price D; On Behalf Of The Kigs International Board Acta Paediatr; 2006 Oct; 95(10):1284-90. PubMed ID: 16982503 [TBL] [Abstract][Full Text] [Related]
15. Long-term Effects of Growth Hormone Replacement Therapy in Childhood-onset Craniopharyngioma: Results of the German Craniopharyngioma Registry (HIT-Endo). Boekhoff S; Bogusz A; Sterkenburg AS; Eveslage M; Müller HL Eur J Endocrinol; 2018 Oct; 179(5):331-341. PubMed ID: 30139824 [TBL] [Abstract][Full Text] [Related]
16. Endocrine and growth features in childhood craniopharyngioma: a mono-institutional study. Di Battista E; Naselli A; Queirolo S; Gallarotti F; Garré ML; Milanaccio C; Cama A J Pediatr Endocrinol Metab; 2006 Apr; 19 Suppl 1():431-7. PubMed ID: 16700321 [TBL] [Abstract][Full Text] [Related]
17. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence. Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640 [TBL] [Abstract][Full Text] [Related]
18. Replacement therapy with growth hormone and pituitary tumor recurrence: the relevance of the problem. Losa M; Gatti E; Rossini A; Lanzi R J Endocrinol Invest; 2008 Sep; 31(9 Suppl):75-8. PubMed ID: 19020392 [TBL] [Abstract][Full Text] [Related]
19. [Pre- and postoperative endocrine function in children with craniopharyngioma ]. Lucas C; Benderitter T; Choux M Arch Fr Pediatr; 1982 May; 39(5):303-7. PubMed ID: 7125828 [TBL] [Abstract][Full Text] [Related]
20. [Growth hormone deficiency in children and adults]. Krysiak R; Okopień B; Herman ZS Pol Merkur Lekarski; 2005 Nov; 19(113):704-9. PubMed ID: 16498817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]